Abstract: A system with a containment assembly formed by containment panels in an array about an interior of the assembly, and a ventilation apparatus for permitting passive air movement and producing active air movement through the interior. The ventilation apparatus may include an active air movement structure to produce active air movement into the interior. The active air movement structure may include at least one air entry opening located on the containment assembly toward the first end, at least one air exit opening located on the containment assembly toward the second end, and an air movement assembly positioned with respect to the containment assembly to create air movement in the interior of the containment assembly. Embodiments of the ventilation apparatus may include a passive air movement structure with at least one ventilation slot in the containment assembly and situated to permit a cross flow of air through the interior.

Abstract: A system with a containment assembly formed by containment panels in an array about an interior of the assembly, and a ventilation apparatus for permitting passive air movement and producing active air movement through the interior. The ventilation apparatus may include an active air movement structure to produce active air movement into the interior. The active air movement structure may include at least one air entry opening located on the containment assembly toward the first end, at least one air exit opening located on the containment assembly toward the second end, and an air movement assembly positioned with respect to the containment assembly to create air movement in the interior of the containment assembly. Embodiments of the ventilation apparatus may include a passive air movement structure with at least one ventilation slot in the containment assembly and situated to permit a cross flow of air through the interior.

Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.

Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.

Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.

Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.

Abstract: The present invention provides polynucleotides that can specifically hybridise to Hepatitis B virus (HBV) nucleic acids from all genotypes. These polynucleotides can be used in genotype-independent detection and quantitation of HBV nucleic acids. For example, the polynucleotides can be used as primers and/or probes in amplification-based assays for either end-point detection or real-time monitoring of HBV nucleic acids in a test sample. The polynucleotides can additionally be provided as part of a kit for the detection and quantitation of HBV nucleic acids.

Abstract: The present invention provides polynucleotides that can specifically hybridise to Hepatitis B virus (HBV) nucleic acids from all genotypes. These polynucleotides can be used in genotype-independent detection and quantitation of HBV nucleic acids. For example, the polynucleotides can be used as primers and/or probes in amplification-based assays for either end-point detection or real-time monitoring of HBV nucleic acids in a test sample. The polynucleotides can additionally be provided as part of a kit for the detection and quantitation of HBV nucleic acids.

Abstract: A structure arrangement and method for the protection of a host system against an impacting ballistic element and for providing ease of mobility. The structure arrangement includes a composite. The composite includes a matrix and a multiplicity of single-walled carbon nanotubes. The single-walled carbon nanotubes are arranged with respect to the matrix so as to define an array for engagement with an impacting ballistic element.

Abstract: The invention relates to multiplex ligase chain reaction (LCR). Two or more putative target sequences are selected. For each one, a set of four probes is used simultaneously to amplify the putative sequence if it is present in the sample. Preferably, all the amplicons are labeled with a common label/hapten and, for each different target, with a unique label/hapten. The invention also relates to an immunochromatographic strip device and method employing a diagonal array of capture spots.

Abstract: The invention relates to multiplex ligase chain reaction (LCR). Two or more putative target sequences are selected. For each one, a set of four probes is used simultaneously to amplify the putative sequence if it is present in the sample. Preferably, all the amplicons are labeled with a common label/hapten and, for each different target, with a unique label/hapten. The invention also relates to an immunochromatographic strip device and method employing a diagonal array of capture spots.

Abstract: The invention relates to multiplex ligase chain reaction (LCR). Two or more purative target sequences are selected. For each one, a set of four probes is used simultaneously to amplify the putative sequence if it is present in the sample. Preferably, all the amplicons are labeled with a common label/hapten and, for each different target, with a unique label/hapten. The invention also relates to an immunochromatographic strip device and method employing a diagonal array of capture spots.